Introduction
============

The function of the larynx includes deglutition, phonation and facilitates respiration. Laryngeal carcinoma is a common malignant tumor that is primarily treated by surgical resection ([@b1-ol-0-0-6709]). The patient\'s stress level after surgical resection (in addition to side effects of radiotherapy and chemotherapy) is increased due in part to the close association between the structure and function characteristics of larynx and hosts nutritional status. Patients, while under the body\'s high metabolic status after surgery, can often develop varying degrees of eating disorders and a relative malnutrition state that can negatively impact the patient\'s quality of life ([@b2-ol-0-0-6709],[@b3-ol-0-0-6709]). To prevent or reverse the postoperative nutritional problems, attention directed to nutritional support therapies may have a great significance in order to prolong the patient\'s survival time and reduce the mortality rate ([@b4-ol-0-0-6709]). A Hospital to Home (H2H) nutrition management model is an individualized nutrition management strategy proposed by the clinical nutrition department in West China Hospital of Sichuan University (Chengdu, China), with the objective to extend nutritional therapy from hospital to discharge and transform a single treatment approach into therapeutic regimen with multiple models. The purpose of this investigation is to determine the effectiveness of a H2H nutrition management model on the postoperative clinical outcome of patients with surgically treated laryngeal carcinoma.

Materials and methods
=====================

Eighty-six patients with laryngeal carcinoma admitted to Weifang People\'s Hospital (Shandong, China) from October 2014 to September 2015, were selected for possible study inclusion. Inclusion criteria: Patients with a confirmed diagnosis of laryngeal carcinoma by computed tomography (CT) or magnetic resonance imaging (MRI) who did not receive radiotherapy or chemotherapy before operation; who underwent surgical resection; who had an expected survival period of more than 3 months; and who had signed an informed consent. Patients were excluded if they had abnormal coagulation function, or obnubilation or a communication barrier. Patients were randomly divided (using a random number table) into either an observation (n=43) or control group (n=43) and demographic data were recorded.

All the patients were treated with surgery; the nutritional status was comprehensively evaluated before treatment, and an early nutritional screening was conducted. The control group received routine nutritional support therapy after surgery; the nasogastric tube was indwelt before operation and enteral nutritional support was given at 48 h postoperative; patients were given a gradual increase of Nutrison Fibre (Nutricia Pharmaceutical Co., Ltd., Wuxi, China) by continuous micro-pumping (pump speed as 50--100 ml/h); nutritional support was given to patients after the caloric requirement was calculated according to 20--30 kcal/(kg·day) standard within the 1st to 3rd day of nutritional therapy, and the total volume was increased to 2,000 ml from the 4th day. Nutrient solution temperature was maintained at 37°C by infusion thermostat, and gastric juice was pumped back every 5 h and observed; when the gastric juice volume was more than 200 ml, the pumping was stopped temporarily. The nutrient solution infusion volume was gradually decreased when patients could take food by mouth, and the total calorie intake was no less than 25 kcal/(kg·day).

The observation group was treated with the H2H nutrition management model; the individualized therapeutic regimen was formulated according to the results of nutritional screening before surgery: i) Preoperative nutritional support therapy: Nutritional education was performed for patients and their families; for patients with well nutrition or mild malnutrition, glucose and electrolyte infusion were taken before surgery, and for patients with moderate to severe malnutrition, parenteral nutritional support was administered; ii) postoperative nutritional therapy during hospitalization: Early enteral nutritional support was taken, within 24 h after operation, and the specific methods were the same as those in the control group; and iii) nutrition therapy outside the hospital: Patients were maintained with nutritional support by continuous nutritional therapy until 6 weeks after discharge.

Before surgery, patients orally ingested 2 g lactulose and 1 g mannitol on an empty stomach; lactulose and mannitol with the same grams were injected into nutritive canal on the 1st, 7th and 14th postoperative day, and the total urine of patients was collected within 6 h, adding dimethylbenzene, and then storing it at −20°C, before analysis. The samples were thawed, centrifuged 3,650 × g for 5 min; and the protein and ions were removed. To the supernatant was added acetonitrile, mixing uniformly, and then centrifuging at 1,050 × g for 10 min. Protein and ion were removed, and the supernatant was isolated. The lactulose and mannitol were respectively prepared for the samples with concentrations of 1,000, 500, 200, 100 and 50 mg/l by ultrapure water, and detected by the high-performance liquid chromatography differential detection method. The concentration of lactulose and mannitol was calculated in accordance with standard curve computational formula, and the ratio of lactulose to mannitol (L/M) was calculated.

Venous blood (5 ml) was collected before operation and on the 1st, 7th and 14th postoperative day and centrifuged 2,750 × g for 20 min for 20 min; supernatant was collected and stored at −20°C. The serum orexin-A level of patients was determined by enzyme-linked immunosorbent assay (ELISA), using kits (Shanghai Jiang Lai Biotechnology Co., Ltd., Shanghai, China) according to the manufacturer\'s instructions. At postoperative 3 months, 10 ml fasting peripheral venous blood was used to determine levels of hemoglobin (Hb), albumin (Alb), prealbumin (PAB) and transferrin (TRF) using a fully automatic biochemical analyzer.

All patients were followed-up for 1 year, and the readmission rates and mortality rates were recorded; all patients were regularly re-examined in the out-patient department; patients in the observation group were followed up by WeChat network platform, mobile APP, telephone and family visit. A home visit was performed for patients treated with home parenteral nutritional support by community physicians every week.

The total urine was collected within 6 h after patients orally ingested the lactulose and mannitol before operation and on the 1st, 7th and 14th postoperative day, and L/M was detected by the high-performance liquid chromatography differential detection method and recorded; 5 ml venous blood was analyzed before surgery and on the 1st, 7th and 14th postoperative day and serum orexin-A level of patients was determined by ELISA.

At postoperative 3 months, 10 ml fasting peripheral venous blood was analyzed for levels of Hb, Alb, PAB and TRF using a fully automatic biochemical analyzer. The nutritional status of patients in the two groups was evaluated by PG-SGA quantitation, and the grade standards were: i) Good nutrition, PG-SGA score ≤1 point; ii) mild/moderate malnutrition, 2 points ≤ PG-SGA score ≤8 points; and iii) severe malnutrition, PG-SGA score ≥9 points.

At postoperative 6 months, the quality of life of patients was assessed by Quality of Life Questionnaire-Core 30 (QLQ-C30) ([@b5-ol-0-0-6709]), and the scoring was respectively completed from 5 dimensions, including body function, role function, cognitive function, emotional function and social function; the original score was converted into centesimal system by linear formula; the higher score correlated to a higher quality of life.

The hospitalization time, hospitalization cost and incidence rate of postoperative complication of patients were determine after the one year follow-up and the readmission rate and mortality rate of patients in the two groups were compared.

Data were processed using SPSS 19.0 (SPSS, Inc., Chicago, IL, USA). Measurements were expressed as mean ± standard deviation (mean ± SD), and t-test was utilized; enumeration data were expressed by ratio and Chi-square test was utilized. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

The demographic data of patients between the two groups was not statistically different (p\>0.05) ([Table I](#tI-ol-0-0-6709){ref-type="table"}). Before operation, and on the 1st, 7th and 14th postoperative day, L/M in the observation group were 0.41±0.12, 0.95±0.23, 0.73±0.14 and 0.54±0.13, respectively, and were 0.42±0.11, 0.96±0.24, 0.85±0.15 and 0.76±0.14 in the control group; before operation and on postoperative 1st, 7th and 14th day, orexin-A levels in the observation group were 8.32±2.14, 16.86±4.28, 13.47±3.26 and 10.63±1.08 ng/l, respectively, and were 8.67±2.34, 17.24±4.35, 16.49±3.42 and 13.63±1.39 ng/l in the control group; L/M and orexin-A levels of patients in the two groups on the 1st postoperative day were significantly higher than those before operation, which were decreased from the 7th and 14th postoperative day, but higher than those before operation (p\<0.05); there were no statistical differences between the two groups before operation and on the 1st postoperative day (p\>0.05), and the indexes in the observation group were significantly decreased than those in the control group on the 7th and 14th postoperative day ([Figs. 1](#f1-ol-0-0-6709){ref-type="fig"} and [2](#f2-ol-0-0-6709){ref-type="fig"}).

The serum Hb, Alb, TRF and PAB of patients between the two groups at 3 months postoperative were compared ([Table II](#tII-ol-0-0-6709){ref-type="table"}). Alb and Hb of patients in the observation group were significantly lower (p\<0.05) than those in the control group, the levels of TRF and PAB in the observation group were significantly higher (p\<0.05) than those in the control group (p\<0.05).

The nutritional status of patients was determined using PG-SGA quantitation ([Fig. 3](#f3-ol-0-0-6709){ref-type="fig"}). The mild/moderate and severe malnutrition rates in the observation group were 41.86% (18/43) and 11.63% (5/43), respectively, which were 53.49% (23/43) and 30.23% (13/43) in the control group; the malnutrition rates were significantly lower in the observation group than those in the control group (p\<0.05).

The incidence rate of postoperative complication, hospitalization time and hospitalization cost of patients in the two groups were compared ([Table III](#tIII-ol-0-0-6709){ref-type="table"}). There were no statistical differences in comparison of hospitalization time and hospitalization cost of patients between the two groups (p\>0.05), and the incidence rate of postoperative complication in the observation group was significantly lower than that in the control group (p\<0.05).

The readmission rate and mortality rate of patients in the two groups after one-year follow-up were compared ([Table IV](#tIV-ol-0-0-6709){ref-type="table"}). The readmission rate and mortality rate in the observation group (9.30 and 6.97%) were significantly lower (p\<0.05) than the control group (34.88 and 30.23%).

The quality of life of patients between the two groups after one-year follow-up (deceased patients were excluded) were compared ([Table V](#tV-ol-0-0-6709){ref-type="table"}). Each dimension score of quality of life in the observation group was significantly higher (p\<0.05) than the control group.

Discussion
==========

Laryngeal carcinoma is one of the most common malignant tumors in otorhinolaryngology head and neck surgery, accounting for 1 to 5% of systemic tumor, and its incidence rate is increasing ([@b6-ol-0-0-6709]). Approximately, 30 to 90% of cancer patients will be malnourished (the malnutrition rate in patients with laryngeal carcinoma is higher than in those with other cancers) and \~20% of patients with cancer will be deceased due to malnutrition and related complications ([@b7-ol-0-0-6709]). Multiple factors can lead to malnutrition in patients with laryngeal carcinoma, including therapy, tumor load and psychological factors ([@b8-ol-0-0-6709]). Generally, patients with laryngeal carcinoma cannot eat food by mouth for about two weeks after surgery. From surgery, the integrity of laryngeal physiological function can be damaged which can cause partial or total loss of its protective effects, leading to dysphagia. In addition, the host caloric needs can be increased by blood loss during and after surgery, pain and other stress responses, resulting in a loss of appetite, gastrointestinal symptoms and oral infections. These factors of an increased caloric need and a decreased dietary caloric intake can lead to weight loss and reduced subcutaneous fat, thus inducing or aggravating malnutrition ([@b9-ol-0-0-6709],[@b10-ol-0-0-6709]).

Nutritional oncology is an area of combined nutrition theory and methods for the prevention (can accurately evaluate nutritional status of patients with cancer to diagnose malnutrition early in the disease/treatment process) and treatment (provide appropriate nutritional support therapy) of cancer patients) ([@b11-ol-0-0-6709]). Most of the traditional nutritional therapies focus on the nutritional status of patients only during hospitalization after surgery, and often neglect the nutritional status of the patients outside the hospital. After discharge of patients with laryngeal carcinoma, anorexia, nausea, vomiting and other symptoms often occur after postoperative radiotherapy and chemotherapy, and in particular, metabolic disorders caused by cachexia can appear in patients with advanced laryngeal carcinoma; therefore, it is necessary to improve the nutrition maintenance therapy of patients once outside the hospital ([@b12-ol-0-0-6709]--[@b14-ol-0-0-6709]). The H2H nutrition management model is a comprehensive treatment model with the patient at the center with continuous nutrition therapy for that patient from hospitalization to outside the hospital; the model uses a team approach involved by many medical disciplines (specialist physician, nutritionist, community physician, nurse and patient\'s family), which can improve patient compliance with nutritional therapy and minimize or ameliorate the status of malnutrition in patients. The results of this study showed the readmission and mortality rate in the observation group were distinctly lower than those in the control group (p\<0.05), which demonstrates the validity of improved patient outcomes with the implementation of the H2H nutrition management model.

The results of this study showed that orexin-A levels and L/M of patients in the two groups on the 1st postoperative day were significantly higher than those before operation, and decreased from postoperative 7th and 14th day, but higher than those before operation (p\<0.05); there were no statistical differences between the two groups before operation and on postoperative 1st day (p\>0.05), and the indexes in the observation group were significantly decreased over the control group on the 7th and 14th postoperative day (p\<0.05); the increase of L/M reveals that the tight junction of intestinal mucosa is incomplete, permeability is increased, and intestinal barrier function is damaged ([@b15-ol-0-0-6709],[@b16-ol-0-0-6709]); the possible causes include: i) Intestinal secretory immunoglobulin A content in patients treated by surgery is decreased; ii) intestinal colonization resistance is reduced and iii) the normal intestinal function is inhibited. Many inflammatory mediators can be activated by the stress response of surgical trauma; for example the gastrointestinal mucosal barrier can be damaged by interleukin (IL) and tumor necrosis factor-α (TNF-α) and an excess amount of NO production, that is induced by TNF-α, can cause microcirculation congestion resulting in damage to the integrity of intestinal membrane barrier ([@b17-ol-0-0-6709]). Early enteral nutritional support during hospitalization, and continuous parenteral nutritional support after discharge, can provide the necessary fuel for the host to repair the injury of intestinal epithelium and effectively protect the chemical barrier of intestinal mucosa; this recovery of the intestinal barrier function is gradual and aids in amelioration of the patients\' malnourished status ([@b18-ol-0-0-6709]). Orexin-A, is a neuropeptide that can regulate the body\'s energy metabolism and improve appetite ([@b14-ol-0-0-6709]). The related experiment reveals that neuron of appetite function can be inhibited by orexin-A, which can excite hypothalamic NPY/cocaine- and amphetamine-regulated transcript peptide neuron, thus promoting the increase of body\'s food intake and weight ([@b15-ol-0-0-6709]). The increased expression level of orexin-A caused by postoperative fasting will promote the patient\'s appetite and with the support of postoperative enteral nutrition, especially early nutritional support, food intake is increased and the body\'s energy metabolism is improved, thereby gradually downregulating orexin-A expression to the normal level.

The results of this study indicated that the incidence rate of postoperative complication in the observation group was significantly lower than that in the control group (p\<0.05). It appears that early enteral nutritional support can effectively reduce bacterial endotoxin translocation, stimulate secretion of digestive juice and gastrointestinal hormones, promote normal gastrointestinal peristalsis, and effectively avoid severe consumption of high catabolism caused by prolonged postoperative fasting, allowing the host metabolic state to return to the normal (early recovery of preoperative nutritional status and improved body\'s negative nitrogen balance) and prevent the occurrence of postoperative complications caused by malnutrition ([@b19-ol-0-0-6709]). Results from this investigation noted that between the two groups, serum Alb and Hb of patients in the observation group were significantly lower than those in the control group, and the levels of TRF and PAB in the observation group were significantly higher than the control group, suggesting that the nutritional level of patients intervened by the H2H nutrition management model is significantly ameliorated, thus reducing the incidence rate of malnutrition.

Currently, PG-SGA evaluation is utilized for patients with laryngeal carcinoma to screen for malnutrition risk. Advantages of this tool is that it can quantitatively evaluate patient\'s nutritional status from measurement of upper limb muscle circumference, triceps skinfold thickness, maximum circumferential diameter of crus, grip strength of non-handedness and body mass index (BMI) ([@b20-ol-0-0-6709]). By adopting the H2H nutrition management model, PG-SGA evaluation showed that malnutrition rates were significantly lower in the observation group than the control group, and each dimension score of quality of life in the observation group was distinctly higher than the control group (p\<0.05). It should be emphasized that the nutritional therapy of patients administered by the H2H nutrition management model is not static after hospital discharge; a continuous and individualized nutritional support therapy is implemented for patients through PG-SGA evaluation; the follow-up is regularly conducted, and the intake, body weight change, and effect of nutritional support therapy, of patients are observed; in addition, effective psychological counseling is also important to manage the patients with depression, self-abasement and other social barriers, in order to improve patients\' quality of life.

In conclusion, the H2H nutrition management model can ameliorate the postoperative malnutritional status of patients with laryngeal carcinoma, reduce the incidence rate of malnutrition and postoperative complication and improve the postoperative quality of life of patients, thus promoting an effective and rational utilization of medical resources.
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![Evaluating nutritional status of patients by PG-SGA quantitation; comparisons between the two groups, p\<0.05. PG-SGA, Patient-Generated Subjective Global Assessment.](ol-14-04-4059-g02){#f3-ol-0-0-6709}

###### 

Comparison of baseline data of patients between the two groups.

  Items                    Control group (n=43)   Observation group (n=43)   t/χ^2^   P-value
  ------------------------ ---------------------- -------------------------- -------- ---------
  Sex (male/female)        24/19                  21/22                      0.420    0.517
  Age (years)              45--76                 45--75                              
  Average age (years)      55.76±6.43             56.03±6.56                 0.193    0.847
  Operation time (min)     203.54±61.17           204.43±61.36               0.067    0.947
  Tumor staging (n, %)                                                                
    I--II                  23 (53.49)             21 (48.84)                 0.186    0.666
    III--IV                20 (46.51)             22 (51.16)                 0.186    0.666
  Operation mode (n, %)                                                               
    Partial laryngectomy   17 (39.53)             15 (34.88)                 0.199    0.655
    Total laryngectomy     26 (60.47)             28 (63.12)                 0.199    0.655

###### 

Comparison of postoperative serum nutritional indexes of patients between the two groups.

  Groups        Case   Hb (g/l)     Alb (g/l)    PAB (g/l)   TRF (g/l)
  ------------- ------ ------------ ------------ ----------- -----------
  Observation   43     93.43±5.38   38.52±3.59   0.26±0.09   1.76±0.34
  Control       43     96.57±5.76   41.41±3.63   0.18±0.06   1.38±0.47
  t-test               2.612        3.712        4.850       4.296
  P-value              0.011        \<0.001      \<0.001     \<0.001

Hb, hemoglobin; Alb, albumin; PAB, prealbumin; TRF, transferrin.

###### 

Therapeutic effects of patients in the two groups.

  Groups        Case   Hospitalization time (days)   Hospitalization cost (thousand RMB)   Postoperative complication (n, %)
  ------------- ------ ----------------------------- ------------------------------------- -----------------------------------
  Observation   43     11.82±3.23                    2.73±1.24                             3 (6.98)
  Control       43     12.14±3.24                    2.65±1.38                             12 (27.91)
  t/χ^2^               0.459                         0.283                                 5.174
  P-value              0.647                         0.778                                 0.023

###### 

Comparison of adverse reactions of patients between the two groups (n, %).

  Groups        Case   Readmission rate   Mortality rate
  ------------- ------ ------------------ ----------------
  Observation   43     4 (9.30)           3 (6.98)
  Control       43     15 (34.88)         13 (30.23)
  χ^2^                 6.756              6.223
  P-value              0.009              0.012

###### 

Comparisons of quality of life of patients between the two groups.

  Groups        Case   Body function   Role function   Cognitive function   Emotional function   Emotional function
  ------------- ------ --------------- --------------- -------------------- -------------------- --------------------
  Observation   40     91.62±3.23      92.73±1.24      88.72±3.23           72.73±3.24           87.73±5.44
  Control       30     83.74±3.24      84.65±1.38      80.34±3.24           64.65±3.38           82.65±6.38
  t/χ^2^               10.088          25.704          10.728               10.136               3.590
  P-value              \<0.001         \<0.001         \<0.001              0.001                0.001
